{
  "meta": {
    "title": "00220_Mid_Day_Pyqs_Neet_Pg_-_Final_36",
    "url": "https://brainandscalpel.vercel.app/00220-mid-day-pyqs-neet-pg-final-36-360375bc.html",
    "scrapedAt": "2025-11-29T18:14:20.099Z"
  },
  "questions": [
    {
      "id": 57626,
      "choices": [
        {
          "id": 229873,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum copper</span></span></p>"
        },
        {
          "id": 229874,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary copper</span></span></p>"
        },
        {
          "id": 229875,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver copper levels</span></span></p>"
        },
        {
          "id": 229876,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ceruloplasmin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient had a history of hepatic dysfunction, and the physical examination finding of the eye is shown below. Which of the following is the best way for confirmation of the diagnosis in this patient? (NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf4.jpg\" style=\"height:296px; width:300px\" /></span></span></p>",
      "unique_key": "Q2509717",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Liver copper levels</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image shows a <strong>Kayser-Fleischer ring,</strong> which is a brownish or gray-green ring at the corneal margin, characteristic of Wilson&#39;s disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wilson&#39;s disease is a disorder of copper metabolism leading to the accumulation of copper in various body tissues, including the liver, brain, and eyes. The Kayser-Fleischer ring, combined with hepatic dysfunction, strongly suggests Wilson&rsquo;s disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most reliable method for confirming the diagnosis of Wilson&rsquo;s disease is measuring liver copper levels. Elevated hepatic copper content (greater than 250 &micro;g/g dry weight) is diagnostic of Wilson&rsquo;s disease, reflecting the abnormal accumulation of copper in liver tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum copper:</span></strong><span style=\"font-size:12.0pt\"> Serum copper levels are usually low in Wilson&rsquo;s disease because copper is not adequately bound to ceruloplasmin. However, this test is not specific or reliable enough to confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Urinary copper:</span></strong><span style=\"font-size:12.0pt\"> Urinary copper excretion is typically elevated in Wilson&#39;s disease and can be used as a supportive test but is not the gold standard for confirmation. It is often used to monitor treatment response rather than for initial diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum ceruloplasmin:</span></strong><span style=\"font-size:12.0pt\"> Serum ceruloplasmin levels are often low in Wilson&#39;s disease, but this is not specific and can be influenced by other factors, making it unreliable as a sole diagnostic tool.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver copper levels measured from a liver biopsy are the most definitive and confirmatory test for diagnosing Wilson&rsquo;s disease, especially when characteristic signs like Kayser-Fleischer rings are present.</span></span></span></p>",
      "correct_choice_id": 229875,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57168,
      "choices": [
        {
          "id": 228061,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung Abscess</span></p>"
        },
        {
          "id": 228062,
          "text": "<p><span style=\"font-size:12.0pt;\">TB</span></p>"
        },
        {
          "id": 228063,
          "text": "<p><span style=\"font-size:12.0pt;\">Fungal pneumonia</span></p>"
        },
        {
          "id": 228064,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydropneumothorax</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-164456.jpg\" alt=\"\" width=\"300\" height=\"274\"></span></p>",
      "unique_key": "Q9493123",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350433,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lung Abscess</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a cavity in the lung with an air-fluid level, which is characteristic of a lung abscess. A lung abscess typically appears as a localized collection of pus within the lung, caused by microbial infection, and is usually associated with an air-fluid level within a thick-walled cavity. This radiologic appearance is a hallmark of a lung abscess and distinguishes it from other conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. TB (Tuberculosis):</strong> Tuberculosis can present with thick-walled cavities but typically does not show a distinct air-fluid level as seen in a lung abscess. TB lesions are often more irregular and do not exhibit the same characteristic air-fluid line.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fungal Pneumonia:</strong> Fungal pneumonia often presents with multiple nodules and may display a \"halo sign\" (nodules surrounded by ground-glass opacity). It does not typically present as a single cavity with an air-fluid level.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hydropneumothorax:</strong> This condition is characterized by the presence of both air and fluid in the pleural space, often leading to a visible air-fluid level, but the appearance is generally over a larger portion of the hemithorax and not within a lung cavity itself. It appears more diffuse rather than localized like a lung abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A lung abscess is identified by a cavity with an air-fluid level on imaging, differentiating it from other pulmonary conditions like TB, fungal infections, and hydropneumothorax.</span></p>",
      "correct_choice_id": 228061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55621,
      "choices": [
        {
          "id": 221929,
          "text": "<p><span style=\"font-size:12.0pt;\">Selenium</span></p>"
        },
        {
          "id": 221930,
          "text": "<p><span style=\"font-size:12.0pt;\">Zn (Zinc)</span></p>"
        },
        {
          "id": 221931,
          "text": "<p><span style=\"font-size:12.0pt;\">Cu</span></p>"
        },
        {
          "id": 221932,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following deficiencies is associated with sexual maturation defect and hypogonadism?&nbsp;(INICET MAY 2024)</span></p>",
      "unique_key": "Q5527853",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350804,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Zn (Zinc)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc is an essential trace element that plays a critical role in numerous biological functions, including growth, immune function, and reproduction. Zinc deficiency is associated with several clinical manifestations, among which hypogonadism and delayed sexual maturation are prominent. Hypogonadism refers to a condition where the body does not produce enough sex hormones, which can lead to delayed puberty, underdeveloped secondary sexual characteristics, and infertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The deficiency of zinc impairs the normal functioning of the hypothalamic-pituitary-gonadal axis, leading to decreased production of testosterone in males and estrogen in females. This hormonal imbalance is directly linked to the symptoms of sexual maturation defects observed in zinc-deficient individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc also plays a significant role in wound healing, immune function, and DNA synthesis. Its deficiency can lead to delayed wound healing, impaired immune response, and chronic diarrhea, further exacerbating the clinical picture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Selenium</strong>: Selenium deficiency is primarily associated with oxidative stress-related conditions, such as Keshan disease (a type of cardiomyopathy) and Kashin-Beck disease (a type of osteoarthropathy). It is not typically associated with hypogonadism or sexual maturation defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cu (Copper)</strong>: Copper deficiency can lead to anemia, neutropenia, and neurological issues but is not linked with hypogonadism or delayed sexual maturation. Copper is involved in iron metabolism and the functioning of several enzymes but does not directly impact the hypothalamic-pituitary-gonadal axis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Iron</strong>: Iron deficiency is well-known for causing anemia, particularly microcytic hypochromic anemia, and can lead to symptoms such as fatigue and weakness. While severe iron deficiency can impact overall growth and development, it is not specifically associated with hypogonadism or sexual maturation defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc deficiency is directly linked to hypogonadism and delayed sexual maturation, along with other symptoms such as impaired wound healing, decreased immunity, and chronic diarrhea. Recognizing and correcting zinc deficiency is crucial for preventing these clinical outcomes.</span></p>",
      "correct_choice_id": 221930,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74919,
      "choices": [
        {
          "id": 298573,
          "text": "<p><span style=\"font-size:16px;\">3rd cranial nerve palsy</span></p>"
        },
        {
          "id": 298574,
          "text": "<p><span style=\"font-size:16px;\">Lagophthalmos</span></p>"
        },
        {
          "id": 298575,
          "text": "<p><span style=\"font-size:16px;\">Marcus Gunn jaw-winking syndrome</span></p>"
        },
        {
          "id": 298576,
          "text": "<p><span style=\"font-size:16px;\">Myasthenia gravis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">The mother of a 5-month-old child complains that the child’s upper eyelid moves up and down during breastfeeding. This disappears when the baby is not being fed. What can be the likely cause? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q4099691",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350910,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Marcus Gunn jaw-winking syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Marcus Gunn jaw-winking syndrome is characterized by an abnormal connection between the 3rd and 5th cranial nerve nuclei. The levator palpebrae superioris (normally supplied by CN III) receives aberrant innervation from the pterygoid muscles (supplied by CN V). This results in synkinetic movement of the upper eyelid during jaw movements like sucking, chewing, or speaking. Treatment involves complete disinsertion of the levator muscle (to prevent the synkinetic movements) followed by frontalis sling surgery (for correction of Ptosis).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-20%20124811.jpg\" width=\"660\" height=\"408\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\"><strong>Option A. 3rd cranial nerve palsy</strong>: Results in complete ptosis without any movement. There is no correlation with jaw movements.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Lagophthalmos</strong>: Refers to inability to close the eyes completely, typically seen in facial nerve palsy. Does not involve synkinetic movements with jaw activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Myasthenia gravis</strong>: An autoimmune disorder affecting acetylcholine receptors. Shows progressive ptosis throughout the day without correlation to jaw movements. Responds to ice pack test and edrophonium (Tensilon) test.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Marcus Gunn jaw-winking syndrome as a congenital synkinetic movement of the upper eyelid during jaw activity due to misdirection between CN III and CN V.</span></p>",
      "correct_choice_id": 298575,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72647,
      "choices": [
        {
          "id": 289577,
          "text": "<p><span style=\"font-size:16px;\">PCOS</span></p>"
        },
        {
          "id": 289578,
          "text": "<p><span style=\"font-size:16px;\">Ovarian Cyst&nbsp;</span></p>"
        },
        {
          "id": 289579,
          "text": "<p><span style=\"font-size:16px;\">Endometriosis&nbsp;</span></p>"
        },
        {
          "id": 289580,
          "text": "<p><span style=\"font-size:16px;\">Normal Ovary</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 23-year-old woman with a BMI of 27 presents with increased facial hair (hirsutism), acne, and irregular/delayed periods. An ultrasound is performed, showing characteristic findings. What is the most likely diagnosis? (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FrjyAsq.png\" width=\"529\" height=\"312\"></span></p>",
      "unique_key": "Q9648584",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350905,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) PCOS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The ultrasound image shows the classic <strong>\"string of pearls\"</strong> appearance characteristic of <strong>polycystic ovarian syndrome (PCOS).</strong> This appearance is created by <strong>multiple small follicles</strong> arranged in a peripheral pattern within the ovary. In this case, the diagnosis of PCOS is supported by:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Rotterdam criteria is used to diagnose PCOS. As per this criteria; 2 out of 3 following characteristics should be present:&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Anovulation/oligo ovulation&nbsp;</span></li><li><span style=\"font-size:16px;\">Hyperandrogenism (Clinical: <strong>acne, hirsutism; Biochemical: raised testosterone, DHEAS levels</strong>)&nbsp;</span></li><li><span style=\"font-size:16px;\">Polycystic morphology on USG, one or both ovaries showing small follicles on the periphery of the ovary.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Ovarian Cyst: Incorrect</strong>. A simple ovarian cyst would appear as a single, large, anechoic (dark) structure rather than multiple small follicles.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Endometriosis: Incorrect</strong>. Endometriosis typically appear as well-defined, homogeneous, hypoechoic cysts with internal echoes, often called \"<strong>chocolate cysts</strong>.\" They don't show the characteristic string of pearls appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cRNpjGy.png\" width=\"911\" height=\"678\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Normal Ovary: Incorrect</strong>. A normal ovary would show fewer follicles <strong>(usually 8-10</strong>) and would not demonstrate the characteristic peripheral arrangement seen in PCOS.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The \"<strong>string of pearls</strong>\" appearance on ultrasound, characterized by multiple peripheral follicles in the ovary, is a diagnostic imaging feature of PCOS</span></li><li><span style=\"font-size:16px;\">Rotterdam criteria is the criteria for diagnosing PCOS wherein at least 2 out of 3 of the following should be there:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Oligoovulation (Delayed periods)</span></li><li><span style=\"font-size:16px;\">Hyperandrogenism (clinical or biochemical)</span></li><li><span style=\"font-size:16px;\">Polycystic morphology of ovaries on ultrasound (string of pearls)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KgqDSV5.png\" width=\"652\" height=\"541\"></span></p>",
      "correct_choice_id": 289577,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72647/FMGE_Jan_2025_OBG_Q_-_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72647/FMGE_Jan_2025_OBG_Q_-_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57084,
      "choices": [
        {
          "id": 227725,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endometriosis</span></span></span></p>"
        },
        {
          "id": 227726,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retained suture</span></span></span></p>"
        },
        {
          "id": 227727,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inclusion cyst</span></span></span></p>"
        },
        {
          "id": 227728,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Melanoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient comes after 6 months of vaginal delivery with an episiotomy repair with pain at the site of episiotomy which increases during her periods. On palpation, a nodular lesion is felt. The probable diagnosis is? </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>",
      "unique_key": "Q3149905",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350434,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Endometriosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with pain at the episiotomy site that worsens during her menstrual periods, along with a palpable nodular lesion. This is a classic presentation of scar endometriosis, a condition where endometrial tissue is implanted in the scar tissue of an episiotomy or caesarean section. The ectopic endometrial tissue responds to hormonal changes during the menstrual cycle, leading to cyclical pain, swelling, and sometimes bleeding at the site, which explains the patient&#39;s symptoms. Scar endometriosis often requires surgical excision for treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Retained suture:</span></strong><span style=\"font-size:12.0pt\"> While retained sutures can cause pain, they do not cause cyclic pain associated with menstrual periods and typically do not present as a nodular lesion that grows or bleeds during menstruation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inclusion cyst:</span></strong><span style=\"font-size:12.0pt\"> An inclusion cyst may form at the site of an episiotomy scar but would not be associated with cyclic pain or changes during the menstrual period. Inclusion cysts are usually painless unless infected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Melanoma:</span></strong><span style=\"font-size:12.0pt\"> Melanoma would not typically present with cyclic pain related to menstruation. It is usually a pigmented lesion that may change in size or color, rather than one that causes cyclic bleeding and pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scar endometriosis should be suspected when there is cyclic pain and a nodular lesion at the site of an episiotomy or surgical scar, especially if symptoms correlate with menstrual periods.</span></span></span></p>",
      "correct_choice_id": 227725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84120,
      "choices": [
        {
          "id": 335060,
          "text": "<p><span style=\"font-size:12.0pt;\">Moraxella lacunata</span></p>"
        },
        {
          "id": 335061,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphylococcus aureus</span></p>"
        },
        {
          "id": 335062,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemophilus influenzae</span></p>"
        },
        {
          "id": 335063,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptococcus pneumoniae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organisms causing acute bacterial conjunctivitis is NOT associated with a Polymorphonuclear response? (NEET PG 2017)</span></p>",
      "unique_key": "Q5654450",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Moraxella lacunata</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Moraxella lacunata causes angular bacterial conjunctivitis, which is a distinct clinical entity with different characteristics from typical acute bacterial conjunctivitis. This organism produces a proteolytic enzyme that macerates epithelium at the angles of the eye rather than triggering the classic polymorphonuclear inflammatory response seen with other bacterial pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Staphylococcus aureus</strong>:As the most common cause of bacterial conjunctivitis, Staphylococcus aureus infection typically presents with a marked polymorphonuclear inflammatory response, characterized by neutrophil infiltration in cytological specimens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Haemophilus influenzae</strong>: This organism (especially H. aegyptius/Koch-Weeks bacillus) causes epidemic mucopurulent conjunctivitis with significant polymorphonuclear response, contributing to the characteristic purulent discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Streptococcus pneumoniae</strong>: Pneumococcal conjunctivitis is associated with not only a polymorphonuclear response but also typically presents with petechial subconjunctival hemorrhages, distinguishing it clinically while still maintaining the neutrophilic infiltration pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Angular conjunctivitis caused by Moraxella lacunata has distinct pathophysiology involving epithelial maceration rather than the typical polymorphonuclear infiltration seen with other bacterial conjunctival infections, making it uniquely different in its inflammatory response pattern.</span></p>",
      "correct_choice_id": 335060,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20643,
      "choices": [
        {
          "id": 82535,
          "text": "<p><span style=\"font-size:12.0pt;\">Fossa of Rosenmuller</span></p>"
        },
        {
          "id": 82536,
          "text": "<p><span style=\"font-size:12.0pt;\">Tubal tonsil</span></p>"
        },
        {
          "id": 82537,
          "text": "<p><span style=\"font-size:12.0pt;\">Opening of eustachian tube</span></p>"
        },
        {
          "id": 82538,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure marked <strong>1 </strong>in the image?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p><p>&nbsp;</p><p><img class=\"image_resized\" style=\"aspect-ratio:666/529;width:57.09%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_h954wXp.png\" width=\"666\" height=\"529\"></p>",
      "unique_key": "Q1450672",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350677,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Fossa of Rosenmuller</strong></span></p><p><img class=\"image_resized\" style=\"aspect-ratio:666/529;width:57.73%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5NJf96m.png\" width=\"666\" height=\"529\"></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image represented is the endoscopic view of lateral wall of the nasopharynx. Structure marked 1 is Fossa of Rosenmüller.</span></p><p>1 - FOSSA OF ROSENMULLER</p><p>2 - TORUS TUBARIUS</p><p>3 - POSTERIOR PHARYNGEAL WALL</p><p>4 - EUSTACHIAN TUBE OPENING</p><p><span style=\"font-size:12.0pt;\">Lateral wall of nasopharynx contains Eustachian tube opening in the form of a bulge called torus tubarius and fossa of Rosenmüller lies behind this elevation (most common site of origin for nasopharyngeal carcinoma)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The tubal tonsil is a small lymphoid tissue located at the tubal elevation near the opening of the eustachian tube.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/05/whatsapp-image-2023-06-12-at-190121011038.jpg\" alt=\"\" width=\"700\" height=\"260\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Tubal Tonsil</strong>: Lymphoid tissue near the opening of the Eustachian tube but not visible as marked in this image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Opening of Eustachian Tube</strong>: Located anterior to the Fossa of Rosenmuller, usually at the torus tubarius, not visible in the marked area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adenoid</strong>: Lymphoid tissue located on the posterior wall of the nasopharynx, not in the lateral wall and thus not visible in this specific view.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Fossa of Rosenmuller's familiarity is essential in nasopharyngeal examinations, especially in the context of identifying potential sites for nasopharyngeal carcinoma or other pathologies. Its recognition during endoscopy guides thorough inspection and appropriate clinical interventions.</span></p>",
      "correct_choice_id": 82535,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11201,
      "choices": [
        {
          "id": 44770,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrogenic DI</span></p>"
        },
        {
          "id": 44771,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary polydipsia</span></p>"
        },
        {
          "id": 44772,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary DI</span></p>"
        },
        {
          "id": 44773,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannitol infusion</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with frequent urination, nocturia, and enuresis. 24-hour urine volume was measured and recorded to be 7 liters. The urine osmolarity was 260 mOsm/L. ADH assay was performed and the recorded values were reported as 0.8 pg/mL. An MRI of the brain was performed and T1 weighted indicated the absence of the bright spot. What is the most likely diagnosis? (NEET PG 2018)</span></p>",
      "unique_key": "Q4752231",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350432,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Pituitary DI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of frequent urination, nocturia, and enuresis combined with a large urine output (7 liters) and low urine osmolarity (260 mOsm/L) suggest a deficiency in ADH effect. The low ADH level (0.8 pg/mL) and the absence of the bright spot on T1 weighted MRI (indicative of a pituitary abnormality) further support the diagnosis of Pituitary Diabetes Insipidus (DI). In Pituitary DI, ADH (vasopressin) is not adequately produced by the hypothalamus or released from the posterior pituitary, which leads to reduced water reabsorption in the kidney and subsequent polyuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Approach to Polyuria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Water vs solute diuresis:&nbsp;</strong>(first thing to know)</span></li><li><span style=\"font-size:12.0pt;\">Water diuresis: DI, Primary polydipsia</span></li><li><span style=\"font-size:12.0pt;\"><strong>Solute diuresis:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Glycosuria (Hyperglycemia, SGLT2 inhibitor use)</span></li><li><span style=\"font-size:12.0pt;\">Iatrogenic hyper-osmolar agents (Hypertonic saline, Mannitol, Urea - from high-protein tube feeding, Radiocontrast agents)</span></li><li><span style=\"font-size:12.0pt;\">Salt wasting (e.g., Medullary cystic disease, Diuretics, CSWS, Obstructive uropathy -especially if B/L, resolving ATN)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Before giving desmopressin → S. Na+ should be 145(or) P. Osm should be &gt; 295.</span></li><li><span style=\"font-size:12.0pt;\">If this cannot be achieved (usually due to severe thirst) during water deprivation - Alternative for water deprivation is Hypertonic saline infusion to achieve S. Na &gt; 145 or P. Osm &gt; 295 - then desmopressin test can be performed.</span></li><li><span style=\"font-size:12.0pt;\">Hypertonic saline (to ↑P. Osm) + Plasma AVP measurement in response to ↑ P. Osm due to hypertonic saline. Plasma AVP is unstable and needs stringent storage techniques. Based on AVP levels- can diagnose pituitary vs nephrogenic vs primary polydipsia. Diagnostic accuracy is questionable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm4.jpg\" alt=\"\" width=\"1000\" height=\"594\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>**Plasma Co-Peptin&nbsp;</strong>(analogues to C-peptide of insulin) can be used for central vs nephrogenic DI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nephrogenic DI:&nbsp;</strong>Incorrect because it typically involves normal or high levels of ADH, but the kidneys do not respond to it. The patient's ADH is low, making this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Primary polydipsia:&nbsp;</strong>This is associated with excessive fluid intake leading to large volumes of dilute urine but generally will not affect ADH levels significantly, and the brain MRI would typically be normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mannitol infusion:&nbsp;</strong>This causes an osmotic diuresis due to the mannitol not being reabsorbed in the renal tubules. There is no evidence of mannitol administration in the patient's history.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>MMS algorithm for finding out the cause</u></strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/17/untitled-403.jpg\" alt=\"\" width=\"1000\" height=\"426\"></span></p>",
      "correct_choice_id": 44772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52809,
      "choices": [
        {
          "id": 210725,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute hepatitis B</span></span></span></p>"
        },
        {
          "id": 210726,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute hepatitis C</span></span></span></p>"
        },
        {
          "id": 210727,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic hepatitis B</span></span></span></p>"
        },
        {
          "id": 210728,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic hepatitis C</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents to you with fever, jaundice, and malaise. What is the most likely diagnosis based on the serology reports given below? (NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-HBc (IgM): Positive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HBsAg: Positive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-HBs: Negative</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-HCV antibodies: Negative</span></span></li>\r\n</ul>",
      "unique_key": "Q7744876",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350916,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Acute hepatitis B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The serology results provide crucial information for diagnosing the type of hepatitis the patient has:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">HBsAg (Hepatitis B surface antigen): Positive</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This indicates an active hepatitis B infection, as HBsAg is a marker of infection.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-HBc (IgM) (Hepatitis B core antibody, IgM): Positive</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of IgM anti-HBc indicates a recent infection or acute hepatitis B. IgM is produced early in the infection and suggests that the infection is recent.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-HBs (Hepatitis B surface antibody): Negative</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The absence of anti-HBs indicates that the patient has not resolved the infection or been vaccinated. In the context of acute infection, this is expected as the patient has not yet developed immunity.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-HCV antibodies: Negative</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This indicates that the patient does not have hepatitis C.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Based on these results, the diagnosis is <strong>acute hepatitis B</strong>. The presence of HBsAg and IgM anti-HBc are key indicators of an acute infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute hepatitis C</span></strong><span style=\"font-size:12.0pt\">: This is ruled out by the negative anti-HCV antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic hepatitis B</span></strong><span style=\"font-size:12.0pt\">: Chronic hepatitis B is diagnosed when HBsAg persists for more than six months and is typically associated with IgG anti-HBc, not IgM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chronic hepatitis C</span></strong><span style=\"font-size:12.0pt\">: This is ruled out by the negative anti-HCV antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of HBsAg and IgM anti-HBc in a patient with fever, jaundice, and malaise strongly indicates acute hepatitis B.</span></span></p>",
      "correct_choice_id": 210725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55897,
      "choices": [
        {
          "id": 223021,
          "text": "<p><span style=\"font-size:12.0pt;\">CECT</span></p>"
        },
        {
          "id": 223022,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 223023,
          "text": "<p><span style=\"font-size:12.0pt;\">DNE</span></p>"
        },
        {
          "id": 223024,
          "text": "<p><span style=\"font-size:12.0pt;\">Biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Investigation of choice for JNA? (NEET PG 2024)</span></p>",
      "unique_key": "Q6744099",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350801,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) CECT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Juvenile nasopharyngeal angiofibroma (JNA) is a <strong>highly vascular tumor</strong> found in adolescent males. The investigation of choice for JNA is Contrast-Enhanced Computed Tomography (CECT). CECT is preferred because it effectively delineates the bony margins and the extent of the tumor, including any bone erosion. The contrast enhancement helps in identifying the vascular nature of the tumor, which is crucial in differentiating JNA from other masses in the nasal cavity, such as adenoids or carcinomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. MRI:&nbsp;</strong>MRI is helpful for assessing <strong>orbital and cranial extensions</strong> of the tumor but is not the primary choice for initial diagnosis. It does not provide as clear an image of the bony structures as CECT does.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. DNE (Diagnostic Nasal Endoscopy):</strong> While DNE can visualize a mass in the nasal cavity, it cannot determine the type of mass or its vascular nature. It is less informative than imaging studies in the diagnosis of JNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Biopsy:</strong> Biopsy is contraindicated in suspected JNA due to the high risk of severe bleeding given the vascular nature of the tumor. Attempting a biopsy can lead to significant complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The investigation of choice for diagnosing Juvenile Nasopharyngeal Angiofibroma is CECT due to its ability to define the tumor's vascularity and extent while safely avoiding the complications associated with biopsy</span></p>",
      "correct_choice_id": 223021,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/55897/Neet_Pg_Aug_2024_Ent_Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/55897/Neet_Pg_Aug_2024_Ent_Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57580,
      "choices": [
        {
          "id": 229689,
          "text": "<p><span style=\"font-size:18px;\">Disaster impact – Mitigation – Rehabilitation – Response</span></p>"
        },
        {
          "id": 229690,
          "text": "<p><span style=\"font-size:18px;\">Disaster impact – Response – Rehabilitation – Mitigation</span></p>"
        },
        {
          "id": 229691,
          "text": "<p><span style=\"font-size:18px;\">Rehabilitation – Response – Disaster impact – Mitigation</span></p>"
        },
        {
          "id": 229692,
          "text": "<p><span style=\"font-size:18px;\">Response – Disaster impact – Rehabilitation – Mitigation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Arrange the steps of the Disaster cycle in sequence.</strong><i><strong> [NEET PG 2024]</strong></i></span></p>",
      "unique_key": "Q6403048",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350906,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Disaster impact – Response – Rehabilitation – Mitigation&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The disaster cycle outlines the sequential steps taken in response to a disaster and how communities can prepare and recover from such events. The correct sequence is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Disaster Impact</strong>: This is the immediate occurrence of the disaster event, such as an earthquake, flood, or hurricane, leading to direct damage and disruption.</span></li><li><span style=\"font-size:18px;\"><strong>Response</strong>: Following the impact, emergency measures are taken to save lives, provide first aid, conduct search and rescue, and offer immediate relief such as food, shelter, and medical treatment.</span></li><li><span style=\"font-size:18px;\"><strong>Rehabilitation</strong>: After the initial response, efforts shift to restoring essential services and helping affected communities return to normal. This involves rebuilding infrastructure, ensuring public health, and restoring social and economic activities.</span></li><li><span style=\"font-size:18px;\"><strong>Mitigation</strong>: This final step involves implementing measures to reduce the severity of future disasters. This can include building stronger infrastructure, improving disaster preparedness plans, and promoting community awareness to minimize potential damage.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The correct sequence of the disaster cycle is: Disaster Impact → Response → Rehabilitation → Mitigation.</span></p>",
      "correct_choice_id": 229690,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11356,
      "choices": [
        {
          "id": 45390,
          "text": "<p><span style=\"font-size:12.0pt;\">Prior Infective Endocarditis</span></p>"
        },
        {
          "id": 45391,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial Septal Defect</span></p>"
        },
        {
          "id": 45392,
          "text": "<p><span style=\"font-size:12.0pt;\">Unrepaired Cyanotic Congenital Heart Disease</span></p>"
        },
        {
          "id": 45393,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac transplant with valvulopathy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following according to the latest guidelines is NOT an indication to IE prophylaxis? (Neet pg 2022)</span></p>",
      "unique_key": "Q9273435",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350455,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B.</strong> <strong>Atrial Septal Defect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the latest guidelines, there are specific indications for infective endocarditis (IE) prophylaxis to prevent infection in high-risk patients. These indications include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Prior Infective Endocarditis</strong>: Patients with a history of infective endocarditis are at increased risk for recurrence and hence, are recommended for prophylaxis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prosthetic Valves</strong>: Patients with prosthetic heart valves, especially mechanical valves, are susceptible to infections and require prophylaxis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cardiac Transplant with Valvulopathy</strong>: Those who have undergone cardiac transplant and have developed valvulopathy are also indicated for IE prophylaxis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Congenital Heart Disease</strong>: This includes any unrepaired cyanotic congenital heart disease, repaired congenital heart disease with prosthetic material for the first six months post-repair, or repaired congenital heart disease with residual defects.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atrial Septal Defect (ASD)</strong> is not listed among these high-risk conditions. ASD, especially without significant gradient across the atria or significant shunting, has a very low risk of causing infective endocarditis. Therefore, ASD does not fit into the current guidelines for IE prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Prior Infective Endocarditis:</strong> Prior infective endocarditis significantly increases the risk of recurrent infection, thus requiring IE prophylaxis as per the guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Unrepaired Cyanotic Congenital Heart Disease:</strong> Unrepaired cyanotic congenital heart disease is a high-risk condition for infective endocarditis, necessitating prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cardiac Transplant with Valvulopathy:</strong> Patients who have undergone a cardiac transplant and have valvulopathy are at increased risk for infection and are indicated for IE prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atrial Septal Defect (ASD) is not an indication for infective endocarditis prophylaxis according to the latest guidelines, whereas prior infective endocarditis, prosthetic valves, cardiac transplant with valvulopathy, and certain congenital heart diseases are key indications.</span></p>",
      "correct_choice_id": 45391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8768,
      "choices": [
        {
          "id": 35039,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ferroportin 1</span></span></span></p>"
        },
        {
          "id": 35040,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hephaestin</span></span></span></p>"
        },
        {
          "id": 35041,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Divalent Metal Transporter 1</span></span></span></p>"
        },
        {
          "id": 35042,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Divalent Metal Transporter 2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the transporter of iron into enterocytes? (NEET PG 2018)</span></span></p>",
      "unique_key": "Q1052380",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350676,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Divalent Metal Transporter 1 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iron uptake into enterocytes is primarily facilitated by the Divalent Metal Transporter 1 (DMT1), which actively transports ferrous iron (Fe2+) across the apical membrane of these cells. The process involves several steps:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reduction of Iron</span></strong><span style=\"font-size:12.0pt\">: Luminal non-heme iron, predominantly in the ferric (Fe3+) state, must first be reduced to ferrous (Fe2+) iron. This reduction is carried out by ferrireductases like b cytochromes and STEAP3.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Transport via DMT1</span></strong><span style=\"font-size:12.0pt\">: Once reduced to Fe2+, iron is transported into the enterocytes through DMT1 located on the apical membrane.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Exit from Enterocytes</span></strong><span style=\"font-size:12.0pt\">: After crossing into the enterocyte, Fe2+ destined for the circulation is exported across the basolateral membrane by Ferroportin. This export is coupled with the oxidation of Fe2+ back to Fe3+ by iron oxidases such as hephaestin and ceruloplasmin.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ferroportin 1</span></strong><span style=\"font-size:12.0pt\">: Incorrect as Ferroportin is responsible for the export of iron from enterocytes into the blood, not for iron uptake into enterocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hephaestin</span></strong><span style=\"font-size:12.0pt\">: Incorrect because hephaestin is involved in the oxidation of Fe2+ to Fe3+ during iron export from enterocytes, not in the uptake.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Divalent Metal Transporter 2</span></strong><span style=\"font-size:12.0pt\">: Incorrect as DMT2 is not the primary transporter involved in the uptake of iron into enterocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Divalent Metal Transporter 1 (DMT1) is critical for the uptake of ferrous iron (Fe2+) into enterocytes from the intestinal lumen, functioning in conjunction with enzymes that reduce ferric (Fe3+) to ferrous (Fe2+) iron.</span></span></span></p>",
      "correct_choice_id": 35041,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16134,
      "choices": [
        {
          "id": 64496,
          "text": "<p><span style=\"font-size:12pt;\">Purulent discharge</span></p>"
        },
        {
          "id": 64497,
          "text": "<p><span style=\"font-size:12pt;\">Serous discharge</span></p>"
        },
        {
          "id": 64498,
          "text": "<p><span style=\"font-size:12pt;\">Erythema</span></p>"
        },
        {
          "id": 64499,
          "text": "<p><span style=\"font-size:12pt;\">Induration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">ASEPSIS wound scoring takes all of the following into consideration except:&nbsp;(NEET PG 2020)</span></p>",
      "unique_key": "Q1095562",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350799,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Induration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">ASEPSIS wound score does not take induration into consideration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">ASEPSIS wound score and Southampton wound score are used to determine the severity of the surgical site wound infection (SSI).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>ASEPSIS SCORE</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/screenshot-2024-07-09-153241.jpg\" alt=\"\" width=\"1000\" height=\"505\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Criterion Not Included:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Induration: </strong>Induration (hardening of the tissue) is not included in the ASEPSIS wound scoring system. The criteria focus on discharge, erythema, separation of tissues, bacterial isolation, and additional treatments rather than tissue induration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The ASEPSIS wound scoring system does not include induration as a criterion. It focuses on factors like purulent and serous discharge, erythema, separation of deep tissue, additional treatments, bacterial isolation, and extended hospital stay to evaluate surgical site infections.</span></p>",
      "correct_choice_id": 64499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57298,
      "choices": [
        {
          "id": 228569,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine</span></span></p>"
        },
        {
          "id": 228570,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine</span></span></p>"
        },
        {
          "id": 228571,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lisinopril</span></span></p>"
        },
        {
          "id": 228572,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telmisartan</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person was taking an antihypertensive drug and continued taking it despite developing constipation, dry mouth, and dizziness. He was taking it regularly but forgot to take it during a trip abroad and has now developed a hypertensive emergency. Which antihypertensive was he likely taking? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q7592388",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350606,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Clonidine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine is an alpha-2 adrenergic agonist used in the management of hypertension. One of the common side effects of Clonidine includes dry mouth, constipation, and dizziness, which matches the symptoms described in this case. Additionally, a significant risk associated with Clonidine is the potential for rebound hypertension if the medication is suddenly discontinued, as can happen if a dose is missed. This rebound effect occurs because the body&#39;s sympathetic nervous system experiences a sudden surge in activity once the inhibitory effects of Clonidine are removed, leading to a hypertensive emergency, as seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember &ndash; Clonidine is safe in Pregnancy&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Amlodipine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine is a calcium channel blocker used for hypertension but does not typically cause rebound hypertension. Its side effects more commonly include peripheral edema rather than the symptoms described here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lisinopril:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lisinopril is an ACE inhibitor that does not cause the described side effects of dry mouth, dizziness, and constipation. Additionally, sudden discontinuation of Lisinopril does not lead to a hypertensive emergency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Telmisartan:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telmisartan is an angiotensin II receptor blocker (ARB). It generally does not cause dry mouth, constipation, or dizziness, and discontinuation does not lead to rebound hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine is an antihypertensive medication that can cause dry mouth, constipation, and dizziness, and sudden discontinuation can lead to rebound hypertension, making it crucial for patients to maintain consistent dosing.</span></span></span></p>",
      "correct_choice_id": 228570,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10174,
      "choices": [
        {
          "id": 40662,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">4 acres</span></p>"
        },
        {
          "id": 40663,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">5 acres</span></p>"
        },
        {
          "id": 40664,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">2 acres</span></p>"
        },
        {
          "id": 40665,
          "text": "<p><span style=\"font-size:18px;\">1 acre</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>For a population of 10,000, the land area necessary to implement the controlled tipping using the trench method is: </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
      "unique_key": "Q4736158",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350803,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) 1 acre</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Controlled tipping or controlled burial is&nbsp;similar in principle to sanitary landfill but at a smaller scale that is appropriate in rural areas.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Trench Method—&nbsp;The waste collection truck deposits its load into the trench where the bulldozer spreads and compacts it. Approximately, 1 acre of land is required for a population of 10000 for a depth of 2 feet and usable for 1-year duration</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">For implementing controlled tipping using the trench method, 1 acre of land is sufficient for a population of 10,000, considering a depth of 2 feet and a usage duration of one year.</span></p>",
      "correct_choice_id": 40665,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5209,
      "choices": [
        {
          "id": 20809,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Influenza</span></span></span></p>"
        },
        {
          "id": 20810,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Diphtheria</span></span></span></p>"
        },
        {
          "id": 20811,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Polio</span></span></span></p>"
        },
        {
          "id": 20812,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Typhoid</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaccine that requires strain change due to evolving organism is: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q1451152",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350914,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Influenza</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The influenza vaccine is unique among vaccines because it requires periodic updates or strain changes almost every year. This necessity is due to the evolving nature of the influenza virus, particularly the frequent antigenic changes in its surface glycoproteins (hemagglutinin and neuraminidase). These changes can occur through two primary mechanisms:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antigenic Drift:</span></strong><span style=\"font-size:12.0pt\"> Minor changes that occur gradually over time as the virus replicates. These small genetic mutations can alter the antigenic properties of the virus, necessitating updates to the vaccine to maintain its effectiveness.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antigenic Shift:</span></strong><span style=\"font-size:12.0pt\"> Less frequent but more significant changes that can lead to the emergence of a completely new influenza virus subtype. This can potentially lead to pandemics if the new subtype spreads widely and the population has little to no immunity against it.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Diphtheria:</span></strong><span style=\"font-size:12.0pt\"> The vaccine for diphtheria does not require frequent updates or strain changes. The causative bacterium (Corynebacterium diphtheriae) does not exhibit the same level of antigenic variation that necessitates vaccine modification.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Polio:</span></strong><span style=\"font-size:12.0pt\"> Polio vaccines target stable viral antigens of the poliovirus, which do not undergo frequent antigenic changes, thus not requiring periodic strain updates.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Typhoid:</span></strong><span style=\"font-size:12.0pt\"> Typhoid vaccines, such as those for Salmonella Typhi, also do not require frequent changes in formulation, as the bacterial antigens are relatively stable.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The influenza vaccine must be updated regularly to match the antigenically evolving influenza virus strains, primarily due to antigenic drift (gradual) and shift (drastic). This adaptation is essential to enhance vaccine effectiveness and control the spread of flu each season, highlighting the dynamic challenge of influenza virus surveillance and vaccine formulation.</span></span></span></p>",
      "correct_choice_id": 20809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55761,
      "choices": [
        {
          "id": 222477,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diphtheria booster single dose</span></span></p>"
        },
        {
          "id": 222478,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythromycin</span></span></p>"
        },
        {
          "id": 222479,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diphtheria toxoid full course</span></span></p>"
        },
        {
          "id": 222480,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nothing is required</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">One mother had brought her child for evaluation of diphtheria in which the child had low-grade fever, pseudomembranes over the tonsils, and one sibling is fully immunized. What will be the prophylaxis given to her sibling? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q5030717",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350977,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Erythromycin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Ans.</strong> is Erythromycin. In cases where a household member is diagnosed with diphtheria, <strong>all close contacts, including fully immunized siblings, should be given prophylactic treatment regardless of their immunization status.</strong> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The recommended prophylaxis for contacts is <strong>oral Erythromycin for seven days or a single dose of benzathine penicillin. </strong>This approach aims to prevent the spread of Corynebacterium diphtheriae and the development of active diphtheria lesions in contacts, even if they are asymptomatic and immunized.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Diphtheria booster single dose:</span></strong><span style=\"font-size:12.0pt\"> A booster dose of the diphtheria toxoid is recommended for previously immunized individuals who are diagnosed with diphtheria but are asymptomatic. This does not apply to the contact sibling who is already fully immunized and not infected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Diphtheria toxoid full course:</span></strong><span style=\"font-size:12.0pt\"> A full course of the diphtheria toxoid is not necessary for a fully immunized sibling who is a contact. This option would be considered for individuals who are not up-to-date with their diphtheria vaccinations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nothing is required:</span></strong><span style=\"font-size:12.0pt\"> This option is incorrect because all household contacts of a diphtheria case should receive prophylactic treatment to prevent possible infection and transmission, even if they are asymptomatic and fully immunized.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For fully immunized close contacts of a diphtheria case, the recommended prophylaxis is a seven-day course of oral Erythromycin or a single dose of benzathine penicillin.</span></span></span></p>",
      "correct_choice_id": 222478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33863,
      "choices": [
        {
          "id": 135290,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
        },
        {
          "id": 135291,
          "text": "<p><span style=\"font-size:12.0pt;\">Glipizide</span></p>"
        },
        {
          "id": 135292,
          "text": "<p><span style=\"font-size:12.0pt;\">Empagliflozin</span></p>"
        },
        {
          "id": 135293,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 53-year-old male presented with type 2 diabetes mellitus. Which of the following anti-diabetic drug acts by causing glucosuria?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q8481318",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350800,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Empagliflozin</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Empagliflozin, as an SGLT2 inhibitor, is the drug among the options provided that acts specifically by causing glucosuria. This mechanism is unique to SGLT2 inhibitors and is a direct way of lowering blood glucose levels in type 2 diabetes mellitus. The other drugs listed work through different mechanisms that do not involve the induction of glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Acarbose:</strong> This drug is an alpha-glucosidase inhibitor. It works by slowing down the digestion of carbohydrates in the intestine, thereby reducing the rise in blood glucose after meals. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Glipizide:</strong> Glipizide is a sulfonylurea. It works by stimulating insulin release from the pancreatic beta cells. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Sitagliptin:</strong> Sitagliptin is a DPP-4 inhibitor. It works by increasing the levels of incretin hormones, which increase insulin release and decrease glucagon release in a glucose-dependent manner. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Empagliflozin is an SGLT2 (Sodium-Glucose Co-Transporter-2) inhibitor, works by blocking glucose reabsorption in the kidney, leading to increased glucose excretion in the urine, i.e., glucosuria.</span></p>",
      "correct_choice_id": 135292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35653,
      "choices": [
        {
          "id": 142415,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Exudative retinal detachment&nbsp;</span></p>"
        },
        {
          "id": 142416,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pediatric tuberculosis&nbsp;</span></p>"
        },
        {
          "id": 142417,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Retinopathy of prematurity&nbsp;</span></p>"
        },
        {
          "id": 142418,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Retinoblastoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 2-year-old child’s father brought him for checkup. On examination, there was white pupillary reflex. USG findings shows intraocular mass with calcification in the eye. There is a family history of enucleation. What is the diagnosis?(</span>FMGE Jan 2024)</p>",
      "unique_key": "Q2714149",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350911,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Retinoblastoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Retinoblastoma is a malignant tumor of the retina that typically presents in young children. It often presents with a white pupillary reflex (leukocoria) and may be associated with an intraocular mass with calcification. There is also a familial predisposition to retinoblastoma, which is indicated by the family history of enucleation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Exudative retinal detachment:&nbsp;</strong>Exudative retinal detachment is a condition where fluid accumulates under the retina, leading to detachment. It is not typically associated with a white pupillary reflex or intraocular mass with calcification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pediatric tuberculosis:&nbsp;</strong>Pediatric tuberculosis can affect various organs, including the eyes, but it usually presents with other signs and symptoms such as fever, cough, and weight loss. It is unlikely to present with a white pupillary reflex and intraocular mass with calcification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Retinopathy of prematurity:&nbsp;</strong>Retinopathy of prematurity is a condition affecting premature infants and is characterized by abnormal blood vessel growth in the retina. It does not typically present with a white pupillary reflex or intraocular mass with calcification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:12pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">Retinoblastoma should be considered in a young child with a white pupillary reflex and intraocular mass with calcification, especially in the presence of a family history of enucleation.</span></p>",
      "correct_choice_id": 142418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44300,
      "choices": [
        {
          "id": 176851,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet-based software</span></p>"
        },
        {
          "id": 176852,
          "text": "<p><span style=\"font-size:12.0pt;\">TV-based software</span></p>"
        },
        {
          "id": 176853,
          "text": "<p><span style=\"font-size:12.0pt;\">Digital weighing machine</span></p>"
        },
        {
          "id": 176854,
          "text": "<p><span style=\"font-size:12.0pt;\">Telephone-based software</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the \"ANMOL\" Program for auxiliary nurse midwives?</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q7088391",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350912,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tablet-based software</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">\"ANMOL\" is an abbreviation that stands for \"<strong>ANM</strong> (Auxiliary Nurse Midwife) <strong>ON</strong>line.\" It is a tablet-based software or online monitoring tool (for RCH portal) that is specifically designed for use by auxiliary nurse midwives (ANMs).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ANMOL program allows ANMs to register and track high-risk pregnancies, monitor children with low birth weight, and manage data related to their work at the sub-center level. It serves as a comprehensive monitoring and data management tool for ANMs, enabling them to efficiently carry out their responsibilities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"ANMOL\" program is a tablet-based software or online monitoring tool specifically designed for auxiliary nurse midwives (ANMs) to register and track high-risk pregnancies, monitor children with low birth weight, and manage data at the sub-center level.</span></p>",
      "correct_choice_id": 176851,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13794,
      "choices": [
        {
          "id": 55137,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyaline cartilage</span></p>"
        },
        {
          "id": 55138,
          "text": "<p><span style=\"font-size:12.0pt;\">Elastic cartilage</span></p>"
        },
        {
          "id": 55139,
          "text": "<p><span style=\"font-size:12.0pt;\">Articular cartilage</span></p>"
        },
        {
          "id": 55140,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibrocartilage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the type of cartilage shown in the image below:(NEET PG 2020)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-893.jpg\" alt=\"\" width=\"300\" height=\"225\"></p>",
      "unique_key": "Q4769558",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350915,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Elastic cartilage</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This image displays a type of cartilage called elastic cartilage.</span></li><li><span style=\"font-size:12.0pt;\">These elastic fibers give the cartilage its unique properties of flexibility and resilience, allowing it to easily return to its original shape after being bent or compressed.</span></li><li><span style=\"font-size:12.0pt;\">On microscopy, elastic cartilage consists of:</span><ul><li><span style=\"font-size:12.0pt;\">Chondrocytes within lacunae</span></li><li><span style=\"font-size:12.0pt;\">Elastic fibres in the matrix</span></li><li><span style=\"font-size:12.0pt;\">Perichondrium with outer fibrous layer and the inner cellular layer</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Function:</strong> Maintains the shape of certain structures while allowing great flexibility.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Found in the ear (auricle or pinna), epiglottis, and eustachian tubes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyaline Cartilage</strong>: This is the most common type of cartilage. It appears glassy and smooth under the microscope. The extracellular matrix contains a large amount of type II collagen and is filled with chondrocytes, the cells responsible for cartilage synthesis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Provides smooth surfaces for movement at joints, flexibility, and support.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Found on joint surfaces, the rib tips, sternum, nose, trachea, and larynx.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Articular Cartilage</strong>: A type of hyaline cartilage that covers the surfaces of bones at synovial joints. It has a smooth, slippery surface that decreases friction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Enables bones of a synovial joint to slide over each other with minimal friction, distributes load in the joint, and allows for shock absorption.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Covers the ends of bones in all movable joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fibrocartilage</strong>: This is a tough, dense, and fibrous material that contains a mix of hyaline cartilage and dense collagen fibers.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: Provides rigidity and shock absorption where it's needed, such as in areas of frequent pressure and pulling.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Locations</strong>: Found in intervertebral discs, pubic symphysis, menisci of the knee, and the points where tendons attach to bones.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/07/screenshot-2023-11-07-183118.jpg\" alt=\"\" width=\"1000\" height=\"487\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-895_xnzdQMS.jpg\" alt=\"\" width=\"700\" height=\"432\"></p>",
      "correct_choice_id": 55138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57516,
      "choices": [
        {
          "id": 229437,
          "text": "<p><span style=\"font-size:12.0pt;\">0.01 mg/kg (1ml/kg of 1:10,000 solution)</span></p>"
        },
        {
          "id": 229438,
          "text": "<p><span style=\"font-size:12.0pt;\">0.1 mg/kg (1ml/kg of 1:1000 solution)</span></p>"
        },
        {
          "id": 229439,
          "text": "<p><span style=\"font-size:12.0pt;\">0.001 mg/kg (1ml/kg of 1:1,00,000 solution)</span></p>"
        },
        {
          "id": 229440,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5 mg/kg (1ml/kg of 1:2000 solution)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the recommended dose of adrenaline for a child during cardiac arrest ? (NEET PG 2024)</span></p>",
      "unique_key": "Q7186982",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350802,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 0.01 mg/kg (1ml/kg of 1:10,000 solution)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The recommended dose of adrenaline (epinephrine) for a child during cardiac arrest is 0.01 mg/kg, using a 1:10,000 dilution. Adrenaline is a potent vasoconstrictor and inotrope, meaning it increases heart rate, myocardial contractility, and peripheral resistance, which are all necessary in a cardiac arrest situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: 0.1 mg/kg (1ml/kg of 1:1000 solution):</strong> This dose is incorrect for cardiac arrest and could be dangerous if administered. The 1:1000 solution of adrenaline is typically used for severe allergic reactions (anaphylaxis), not for cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: 0.001 mg/kg (1ml/kg of 1:1,00,000 solution):</strong> This dose is too low to be effective during cardiac arrest and does not match the recommended guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: 0.5 mg/kg (1ml/kg of 1:2000 solution):</strong> This option is incorrect as it does not correspond to the recommended concentration or dose for adrenaline administration in pediatric cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct dose of adrenaline for a child during cardiac arrest is 0.01 mg/kg using a 1:10,000 solution.</span></p>",
      "correct_choice_id": 229437,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57516/Neet_Pg_Aug_2024_Anesthesia_Q_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57516/Neet_Pg_Aug_2024_Anesthesia_Q_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6516,
      "choices": [
        {
          "id": 26033,
          "text": "<p><span style=\"font-size:12.0pt;\">Grapefruit juice</span></p>"
        },
        {
          "id": 26034,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol</span></p>"
        },
        {
          "id": 26035,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepine</span></p>"
        },
        {
          "id": 26036,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI (Selective Serotonin Reuptake Inhibitor)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient has been diagnosed with bacterial vaginosis and trichomoniasis. She is prescribed metronidazole as part of her treatment plan. Which of the following should she avoid consuming while on this medication? (NEET PG 2021)</span></p>",
      "unique_key": "Q6166857",
      "question_audio": null,
      "question_video": null,
      "map_id": 29350678,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Alcohol</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Patients taking metronidazole are advised to avoid alcohol consumption. Metronidazole and alcohol can interact to cause a disulfiram-like reaction, leading to symptoms such as flushing, nausea, vomiting, palpitations, and even more severe reactions in some cases. This interaction can occur not only with oral alcohol consumption but also with alcohol contained in mouthwashes and certain medications.</span></li><li><span style=\"font-size:12.0pt;\">Disulfiram is an aversive drug, that inhibits the aldehyde dehydrogenase, leading to accumulation of acetaldehyde in the body, which can lead to symptoms like throbbing headache, flushing, chest tightness, visual disturbances, nausea etc. Hence these symptoms prevent the patient from taking alcohol.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Grapefruit juice</strong>: There is no known significant interaction between grapefruit juice and metronidazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Benzodiazepine</strong>: While caution may be advised when combining any medications that can have CNS effects, there is not a well-known, specific interaction between benzodiazepines and metronidazole that would warrant absolute avoidance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. SSRI</strong>: Similar to benzodiazepines, there is not a well-known, specific interaction between SSRIs and metronidazole that would warrant absolute avoidance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drugs that can cause disulfiram like reaction include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C</strong>yclic:&nbsp; <strong>C</strong>efoperazone, <strong>C</strong>hlorpropamide</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>G: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; G</strong>rieseofulvin</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>M: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M</strong>etronidazole</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>P: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P</strong>rocarbazine</span></p>",
      "correct_choice_id": 26034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}